Robert Andrade - 21 Sep 2022 Form 4 Insider Report for FENNEC PHARMACEUTICALS INC. (FENC)

Role
CHIEF FINANCIAL OFFICER
Signature
/s/ Robert Andrade, Chief Financial Officer
Issuer symbol
FENC
Transactions as of
21 Sep 2022
Net transactions value
-$162,704
Form type
4
Filing time
22 Sep 2022, 11:02:51 UTC
Previous filing
20 Dec 2021
Next filing
30 Dec 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction FENC Common shares Award $0 +37,500 +24% $0.000000 190,773 21 Sep 2022 Direct F1
transaction FENC Common shares Disposed to Issuer $162,704 -19,052 -10% $8.54 171,721 21 Sep 2022 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On September 21, 2022, 37,500 restricted share units were released from their restriction.
F2 On September 21, 2022, 19,052 shares were netted back to the company to pay the taxes on the common shares released from restriction.